Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood
Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood: A Sequential Multiple Assignment Randomized Trial
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 50 Years to 75 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
To test adaptive intensive behavioral therapy strategies comprising dietary patterns with varying amounts of protein and including supplemental protein or resistance exercise training for promoting weight loss and attenuating lean mass loss in adults aged 50-75 with obesity.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Male or female sex * all racial and ethnic groups * BMI: 30-50 kg/m2 * age 50-75 years * postmenopausal status for ≥1 y if female sex Exclusion Criteria: * \<3 months stable use of other medications affecting body weight or appetite * \>450 pounds (due to weight limitations of the DXA) * indication or previous diagnosis of sarcopenia * existing kidney disease * current binge eating disorder, anorexia, or bulimia * untreated hyper- or hypothyroidism, cancer (except basal cell), gastrointestinal disorders affecting food intake or nutrient absorption; any other medical condition, as determined by the study physician, precluding a HP diet and/or daily exercise
Study sites (1)
AL
- University of Alabama at Birmingham · Birmingham, AL 35233Drew Sayer, MD · Principal investigatorMore trials in Birmingham